KCNH4
gene geneOn this page
Also known as Kv12.3elk1
Summary
KCNH4 (potassium voltage-gated channel subfamily H member 4, HGNC:6253) is a protein-coding gene on chromosome 17q21.2, encoding Voltage-gated delayed rectifier potassium channel KCNH4 (Q9UQ05). Pore-forming (alpha) subunit of a voltage-gated delayed rectifier.
Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a member of the potassium channel, voltage-gated, subfamily H. This member is a pore-forming (alpha) subunit. The gene is brain-specific, and located in the neocortex and the striatum. It may be involved in cellular excitability of restricted neurons in the central nervous system.
Source: NCBI Gene 23415 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 135 total
- Regional missense constraint (gnomAD): 1 of 4 regions constrained (≈1% of expected missense variation)
- GTEx eGene: eQTL in 18 tissues, sQTL in 0 (q < 0.05)
- Constraint (gnomAD): pLI 0.95 (loss-of-function intolerant), LOEUF 0.50 (moderately constrained)
- MANE Select transcript:
NM_012285 - Notable: 135 clinical variants but no curated precision-oncology (CIViC) evidence yet
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:6253 |
| Approved symbol | KCNH4 |
| Name | potassium voltage-gated channel subfamily H member 4 |
| Location | 17q21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Kv12.3, elk1 |
| Ensembl gene | ENSG00000089558 |
| Ensembl biotype | protein_coding |
| OMIM | 604528 |
| Entrez | 23415 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
MANE Select: ENST00000264661
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1, TSL 5: 1
ENST00000264661, ENST00000607371, ENST00001138945
RefSeq mRNA: 1 — MANE Select: NM_012285
NM_012285
CCDS: CCDS11420
Canonical transcript exons
ENST00000264661 — 17 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001059058 | 42175579 | 42175736 |
| ENSE00001059059 | 42171788 | 42171995 |
| ENSE00001059060 | 42170107 | 42170301 |
| ENSE00001059063 | 42178100 | 42178227 |
| ENSE00001059065 | 42178331 | 42178477 |
| ENSE00001059066 | 42176054 | 42176297 |
| ENSE00001059067 | 42178793 | 42179026 |
| ENSE00001136932 | 42180870 | 42181142 |
| ENSE00001179445 | 42162248 | 42162321 |
| ENSE00001179452 | 42163228 | 42163334 |
| ENSE00001179483 | 42164130 | 42164168 |
| ENSE00001179498 | 42166297 | 42166546 |
| ENSE00001179505 | 42169477 | 42169676 |
| ENSE00001231223 | 42163606 | 42163958 |
| ENSE00001231237 | 42165449 | 42165693 |
| ENSE00001231300 | 42159731 | 42160435 |
| ENSE00003696982 | 42156891 | 42157118 |
Expression profiles
Bgee: expression breadth broad, 96 present calls, max score 82.80.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1764 / max 36.3058, expressed in 77 samples.
Highest expression (Bgee): buccal mucosa cell, putamen, male germ line stem cell (sensu Vertebrata) in testis, caudate nucleus, nucleus accumbens.
Genetic regulation across tissues (GTEx eQTL / sQTL)
KCNH4 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 18 tissues and its splicing (sQTL) in 0 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
18 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Adipose Subcutaneous | eqtl | 1.5e-16 | +0.38 | 17:42122855:A:C |
| Esophagus Muscularis | eqtl | 3.2e-08 | +0.40 | 17:42136994:G:A |
| Adipose Visceral Omentum | eqtl | 1.7e-07 | +0.28 | 17:42119952:A:G |
| Breast Mammary Tissue | eqtl | 1.8e-07 | +0.25 | 17:42143379:G:A |
| Nerve Tibial | eqtl | 4.8e-07 | +0.32 | 17:42137747:C:T |
| Muscle Skeletal | eqtl | 3.1e-06 | +0.30 | 17:42122855:A:C |
| Heart Left Ventricle | eqtl | 2.2e-04 | +0.27 | 17:42129045:T:G |
| Skin Not Sun Exposed Suprapubic | eqtl | 5.7e-04 | +0.27 | 17:42141847:T:C |
| Colon Transverse | eqtl | 6.7e-04 | +0.32 | 17:42122182:G:A |
| Esophagus Gastroesophageal Junction | eqtl | 7.8e-04 | +0.34 | 17:42119952:A:G |
| Brain Caudate basal ganglia | eqtl | 3.6e-03 | +0.41 | 17:42180123:G:C |
| Thyroid | eqtl | 5.5e-03 | +0.23 | 17:42122855:A:C |
| Lung | eqtl | 5.6e-03 | +0.26 | 17:42122855:A:C |
| Colon Sigmoid | eqtl | 1.0e-02 | +0.28 | 17:42123884:C:T |
| Small Intestine Terminal Ileum | eqtl | 1.2e-02 | -0.83 | 17:42283439:A:G |
| Artery Tibial | eqtl | 1.4e-02 | +0.19 | 17:42137747:C:T |
| Skin Sun Exposed Lower leg | eqtl | 2.1e-02 | +0.22 | 17:42145640:C:G |
| Heart Atrial Appendage | eqtl | 3.5e-02 | +0.81 | 17:41960992:G:A |
FANTOM5 promoters
2 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 166111 | 0.1072 | 53 |
| 166110 | 0.0692 | 36 |
Top tissues by expression
showing 100 of 215 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 82.80 | gold quality |
| putamen | UBERON:0001874 | 77.67 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 75.97 | silver quality |
| caudate nucleus | UBERON:0001873 | 75.46 | gold quality |
| nucleus accumbens | UBERON:0001882 | 73.02 | gold quality |
| myocardium | UBERON:0002349 | 69.28 | gold quality |
| prefrontal cortex | UBERON:0000451 | 68.32 | gold quality |
| right frontal lobe | UBERON:0002810 | 66.37 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 64.36 | gold quality |
| frontal cortex | UBERON:0001870 | 63.52 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 63.10 | gold quality |
| primary visual cortex | UBERON:0002436 | 63.05 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 62.97 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 62.13 | gold quality |
| neocortex | UBERON:0001950 | 61.54 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 60.36 | gold quality |
| biceps brachii | UBERON:0001507 | 60.16 | gold quality |
| forebrain | UBERON:0001890 | 58.81 | gold quality |
| cerebral cortex | UBERON:0000956 | 57.81 | gold quality |
| secondary oocyte | CL:0000655 | 57.39 | gold quality |
| superficial temporal artery | UBERON:0001614 | 57.29 | gold quality |
| occipital lobe | UBERON:0002021 | 57.24 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 57.08 | gold quality |
| heart right ventricle | UBERON:0002080 | 57.01 | gold quality |
| gingiva | UBERON:0001828 | 56.91 | gold quality |
| vastus lateralis | UBERON:0001379 | 56.61 | gold quality |
| quadriceps femoris | UBERON:0001377 | 56.25 | gold quality |
| oral cavity | UBERON:0000167 | 56.10 | gold quality |
| medial globus pallidus | UBERON:0002477 | 55.95 | gold quality |
| vermiform appendix | UBERON:0001154 | 55.41 | gold quality |
| gingival epithelium | UBERON:0001949 | 55.22 | gold quality |
| brain | UBERON:0000955 | 55.07 | gold quality |
| globus pallidus | UBERON:0001875 | 54.62 | gold quality |
| decidua | UBERON:0002450 | 54.37 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 54.35 | gold quality |
| caecum | UBERON:0001153 | 54.07 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 54.07 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 53.82 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 53.81 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 52.54 | gold quality |
| cartilage tissue | UBERON:0002418 | 52.53 | gold quality |
| amygdala | UBERON:0001876 | 52.12 | gold quality |
| urinary bladder | UBERON:0001255 | 52.09 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 52.06 | gold quality |
| deltoid | UBERON:0001476 | 50.88 | gold quality |
| hypothalamus | UBERON:0001898 | 50.53 | gold quality |
| sperm | CL:0000019 | 49.87 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 49.81 | gold quality |
| stromal cell of endometrium | CL:0002255 | 49.80 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 49.48 | gold quality |
| temporal lobe | UBERON:0001871 | 49.17 | gold quality |
| lymph node | UBERON:0000029 | 48.38 | silver quality |
| subcutaneous adipose tissue | UBERON:0002190 | 48.38 | gold quality |
| bone marrow cell | CL:0002092 | 48.27 | gold quality |
| granulocyte | CL:0000094 | 48.19 | silver quality |
| cardiac ventricle | UBERON:0002082 | 48.02 | gold quality |
| heart left ventricle | UBERON:0002084 | 47.91 | gold quality |
| omental fat pad | UBERON:0010414 | 47.62 | gold quality |
| peritoneum | UBERON:0002358 | 47.60 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 47.27 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 47.11 | gold quality |
| adipose tissue | UBERON:0001013 | 46.60 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 46.19 | gold quality |
| placenta | UBERON:0001987 | 46.12 | gold quality |
| islet of Langerhans | UBERON:0000006 | 45.93 | gold quality |
| right adrenal gland | UBERON:0001233 | 45.87 | gold quality |
| colonic epithelium | UBERON:0000397 | 45.50 | gold quality |
| saphenous vein | UBERON:0007318 | 45.32 | gold quality |
| upper leg skin | UBERON:0004262 | 45.25 | silver quality |
| amniotic fluid | UBERON:0000173 | 45.21 | gold quality |
| Ammon’s horn | UBERON:0001954 | 45.20 | gold quality |
| gall bladder | UBERON:0002110 | 45.17 | silver quality |
| heart | UBERON:0000948 | 45.05 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 44.76 | gold quality |
| colonic mucosa | UBERON:0000317 | 44.68 | gold quality |
| blood | UBERON:0000178 | 44.60 | gold quality |
| apex of heart | UBERON:0002098 | 44.60 | silver quality |
| adrenal gland | UBERON:0002369 | 44.58 | gold quality |
| left adrenal gland | UBERON:0001234 | 44.38 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 44.33 | gold quality |
| small intestine | UBERON:0002108 | 44.23 | gold quality |
| entorhinal cortex | UBERON:0002728 | 44.17 | gold quality |
| tonsil | UBERON:0002372 | 44.10 | silver quality |
| myometrium | UBERON:0001296 | 44.08 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 43.76 | gold quality |
| adrenal cortex | UBERON:0001235 | 43.69 | gold quality |
| adult organism | UBERON:0007023 | 43.44 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 43.31 | gold quality |
| ventricular zone | UBERON:0003053 | 43.28 | gold quality |
| cauda epididymis | UBERON:0004360 | 43.26 | gold quality |
| left uterine tube | UBERON:0001303 | 43.24 | gold quality |
| trachea | UBERON:0003126 | 43.23 | gold quality |
| cortical plate | UBERON:0005343 | 43.22 | gold quality |
| anatomical system | UBERON:0000467 | 43.10 | gold quality |
| oocyte | CL:0000023 | 43.09 | gold quality |
| material anatomical entity | UBERON:0000465 | 43.07 | gold quality |
| multicellular organism | UBERON:0000468 | 43.07 | gold quality |
| uterine cervix | UBERON:0000002 | 43.06 | silver quality |
| jejunum | UBERON:0002115 | 42.99 | gold quality |
| pylorus | UBERON:0001166 | 42.89 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.08 |
HPA expression
RNA tissue specificity: Tissue enriched
52 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM |
|---|---|---|
| Nucleus accumbens | tissue | 17.0 |
| Basal ganglia | tissue | 11.3 |
| Olfactory bulb | tissue | 10.6 |
| Putamen | tissue | 10.3 |
| Caudate putamen | tissue | 9.4 |
| Cerebral cortex | tissue | 7.9 |
| Temporal cortex | tissue | 7.9 |
| Occipital cortex | tissue | 7.5 |
| Ventral forebrain | tissue | 7.1 |
| Somatosensory cortex | tissue | 7.1 |
| Insular cortex | tissue | 6.9 |
| Hippocampal formation | tissue | 6.8 |
| Entorhinal cortex | tissue | 6.8 |
| Prefrontal cortex | tissue | 6.2 |
| Motor cortex | tissue | 5.7 |
| Frontal cortex | tissue | 5.7 |
| Retrosplenial and cingulate cortex | tissue | 5.7 |
| Retrosplenial cortex | tissue | 4.9 |
| Septum | tissue | 3.9 |
| Amygdala | tissue | 3.8 |
| Medulla oblongata | tissue | 3.0 |
| Spinal cord | tissue | 2.9 |
| Substantia nigra | tissue | 2.6 |
| Hypothalamus | tissue | 2.4 |
| Postcentral gyrus | tissue | 2.4 |
| Midbrain | tissue | 2.2 |
| Periaqueductal gray | tissue | 2.1 |
| Pons | tissue | 2.0 |
| Thalamus | tissue | 1.5 |
| Corpus callosum | tissue | 1.5 |
| Superior colliculi | tissue | 1.4 |
| Hippocampus | tissue | 1.1 |
| Locus coeruleus | tissue | 1.0 |
| Cerebellum | tissue | 0.8 |
| Appendix | tissue | 0.5 |
| Urinary bladder | tissue | 0.3 |
| Pituitary gland | tissue | 0.2 |
| Lymph node | tissue | 0.2 |
| Adipose tissue | tissue | 0.2 |
| Choroid plexus | tissue | 0.2 |
| Tonsil | tissue | 0.2 |
| Cervix | tissue | 0.1 |
| Testis | tissue | 0.1 |
| Stomach 1 | tissue | 0.1 |
| Heart muscle | tissue | 0.1 |
| Vagina | tissue | 0.1 |
| Tongue | tissue | 0.1 |
| Spleen | tissue | 0.1 |
| Small intestine | tissue | 0.1 |
| Duodenum | tissue | 0.1 |
| Adrenal gland | tissue | 0.1 |
| Bone marrow | tissue | 0.1 |
Brain sub-regions (HPA Brain Atlas): detected in 189; highest nTPM — Caudate nucleus (25.0), Nucleus basalis of Meynert (22.3), Temporo-occipital transitional zone (9.7), Centromedial thalamic nucleus (8.5), Parietal operculum (7.5).
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
Targeting KCNH4 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
showing 30 of 46 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4425 | 100.00 | 67.59 | 1049 |
| HSA-MIR-6870-5P | 99.99 | 68.55 | 2115 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-4723-5P | 99.97 | 68.70 | 2034 |
| HSA-MIR-5698 | 99.97 | 68.49 | 2029 |
| HSA-MIR-7111-5P | 99.97 | 68.48 | 2062 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-9902 | 99.89 | 69.15 | 2250 |
| HSA-MIR-548AZ-5P | 99.83 | 69.94 | 3230 |
| HSA-MIR-548T-5P | 99.83 | 69.91 | 3220 |
| HSA-MIR-4319 | 99.76 | 69.83 | 2586 |
| HSA-MIR-6794-5P | 99.76 | 66.38 | 1048 |
| HSA-MIR-6887-3P | 99.66 | 67.83 | 1778 |
| HSA-MIR-3175 | 99.65 | 66.30 | 2031 |
| HSA-MIR-3147 | 99.52 | 66.34 | 388 |
| HSA-MIR-671-5P | 99.52 | 67.11 | 1277 |
| HSA-MIR-1275 | 99.47 | 67.90 | 2749 |
| HSA-MIR-125A-5P | 99.36 | 70.59 | 1640 |
| HSA-MIR-125B-5P | 99.36 | 70.36 | 1662 |
| HSA-MIR-6507-3P | 99.35 | 67.32 | 1059 |
| HSA-MIR-6852-5P | 99.17 | 66.69 | 2073 |
| HSA-MIR-939-3P | 98.97 | 65.07 | 2347 |
| HSA-MIR-4451 | 98.82 | 68.17 | 1455 |
| HSA-MIR-4716-5P | 98.82 | 68.57 | 1168 |
| HSA-MIR-4763-5P | 98.75 | 63.89 | 854 |
| HSA-MIR-198 | 98.70 | 67.32 | 920 |
| HSA-MIR-7155-5P | 98.65 | 66.14 | 1290 |
| HSA-MIR-4700-5P | 98.63 | 67.43 | 1915 |
| HSA-MIR-6878-5P | 98.49 | 67.91 | 2142 |
| HSA-MIR-5089-5P | 98.45 | 66.06 | 1388 |
Functional genomics
gnomAD constraint: pLI 0.95, LOEUF 0.5, missense Z 3.38 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD)
ENST00000264661 splits into 4 regions with different missense tolerance; 1 is missense-constrained (≈1% of the expected missense variation). Missense variants in a constrained region (low observed/expected) are more likely to be pathogenic. gnomAD
| Region (GRCh38) | Missense obs / exp | o/e | Constrained |
|---|---|---|---|
| 17:42,160,043–42,165,667 | 441 / 512.3 | 0.86 | no |
| 17:42,165,668–42,175,709 | 318 / 479.6 | 0.66 | no |
| 17:42,175,710–42,176,065 | 2 / 16.7 | 0.12 | yes (p 3.3e-04) |
| 17:42,176,066–42,180,945 | 283 / 378.6 | 0.75 | no |
Cross-species orthologs
15 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | kcnh4b | ENSDARG00000061990 |
| danio_rerio | kcnh4a | ENSDARG00000062565 |
| mus_musculus | Kcnh4 | ENSMUSG00000035355 |
| rattus_norvegicus | Kcnh4 | ENSRNOG00000018790 |
| drosophila_melanogaster | sei | FBGN0003353 |
| drosophila_melanogaster | Elk | FBGN0011589 |
| drosophila_melanogaster | CG6026 | FBGN0038676 |
| drosophila_melanogaster | CngA | FBGN0261612 |
| drosophila_melanogaster | Cngl | FBGN0263257 |
| drosophila_melanogaster | CngB | FBGN0266346 |
| caenorhabditis_elegans | WBGENE00000487 | |
| caenorhabditis_elegans | tax-2 | WBGENE00006525 |
| caenorhabditis_elegans | WBGENE00006526 | |
| caenorhabditis_elegans | WBGENE00006830 | |
| caenorhabditis_elegans | WBGENE00022295 |
Paralogs (17): KCNH2 (ENSG00000055118), CNGB1 (ENSG00000070729), HCN2 (ENSG00000099822), CNGA4 (ENSG00000132259), KCNH3 (ENSG00000135519), HCN4 (ENSG00000138622), KCNH5 (ENSG00000140015), KCNH1 (ENSG00000143473), HCN3 (ENSG00000143630), CNGA3 (ENSG00000144191), HCN1 (ENSG00000164588), CNGB3 (ENSG00000170289), KCNH6 (ENSG00000173826), CNGA2 (ENSG00000183862), KCNH8 (ENSG00000183960), KCNH7 (ENSG00000184611), CNGA1 (ENSG00000198515)
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Oryctolagus cuniculus | Q8WNY2 | 97.4% | Diamond |
| Bos taurus | O18965 | 96.9% | Diamond |
| Canis lupus familiaris | Q9TSZ3 | 96.2% | Diamond |
| Sus scrofa | Q9TUI4 | 96.0% | Diamond |
| Cavia porcellus | O08703 | 95.2% | Diamond |
| Pseudomonas syringae pv. syringae B728a | Q4ZSY3 | 92.7% | Diamond |
| Pseudomonas syringae pv. tomato str. DC3000 | Q881J7 | 92.7% | Diamond |
| Pseudomonas savastanoi pv. phaseolicola 1448A | Q48IV1 | 92.1% | Diamond |
| Beauveria bassiana ARSEF 2860 | J5J1K4 | 72.1% | Diamond |
| Neurospora crassa OR74A | Q01371 | 72.1% | Diamond |
| Brucella anthropi ATCC 49188 | A6X554 | 69.0% | Diamond |
| Fusarium oxysporum f. sp. lycopersici 4287 | A0A0J9UPF5 | 67.2% | Diamond |
| Aspergillus flavus | A0A364LYQ6 | 62.9% | Diamond |
| Gallus gallus | Q9PT84 | 61.4% | Diamond |
| Bacillus subtilis subsp. subtilis str. 168 | O34627 | 50.4% | Diamond |
| Erythrobacter litoralis HTCC2594 | Q2NCA3 | 48.1% | Diamond |
| Halobacterium salinarum NRC-1 | Q9HPU8 | 47.5% | Diamond |
| Arabidopsis thaliana | O64511 | 44.6% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| KAT2A | protein-coding | 2648 |
| HCRT | protein-coding | 3060 |
| RAB5C | protein-coding | 5878 |
| GHDC | protein-coding | 84514 |
| HSPB9 | protein-coding | 94086 |
| RAB5C-AS1 | ncRNA | 105371781 |
| DHX58 | protein-coding | 79132 |
| STAT5A | protein-coding | 6776 |
| STAT5B | protein-coding | 6777 |
| STAT3 | protein-coding | 6774 |
Protein
Protein identifiers
Voltage-gated delayed rectifier potassium channel KCNH4 — Q9UQ05 (reviewed: Q9UQ05)
Alternative names: Brain-specific eag-like channel 2, Ether-a-go-go-like potassium channel 1, Potassium voltage-gated channel subfamily H member 4, Voltage-gated potassium channel subunit Kv12.3
All UniProt accessions (1): Q9UQ05
UniProt curated annotations — full annotation on UniProt →
Function. Pore-forming (alpha) subunit of a voltage-gated delayed rectifier. Activates at more negative voltages, exhibits fast prepulse-independent activation kinetics and deactivates much more slowly, but shows no inactivation.
Subunit / interactions. The potassium channel is probably composed of a homo- or heterotetrameric complex of pore-forming alpha subunits that can associate with modulating beta subunits.
Subcellular location. Membrane.
Tissue specificity. Detected only in brain, in particular in the telencephalon. Detected in putamen and caudate nucleus, and at lower levels in cerebral cortex, occipital and hippocampus.
Similarity. Belongs to the potassium channel family. H (Eag) (TC 1.A.1.20) subfamily. Kv12.3/KCNH4 sub-subfamily.
RefSeq proteins (1): NP_036417* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000014 | PAS | Domain |
| IPR000595 | cNMP-bd_dom | Domain |
| IPR000700 | PAS-assoc_C | Domain |
| IPR001610 | PAC | Repeat |
| IPR003938 | K_chnl_volt-dep_EAG/ELK/ERG | Family |
| IPR003950 | K_chnl_volt-dep_ELK | Family |
| IPR005821 | Ion_trans_dom | Domain |
| IPR014710 | PpnP-like_jellyroll | Homologous_superfamily |
| IPR018490 | cNMP-bd_dom_sf | Homologous_superfamily |
| IPR035965 | PAS-like_dom_sf | Homologous_superfamily |
| IPR050818 | KCNH_animal-type | Family |
Pfam: PF00520, PF13426
Catalyzed reactions (Rhea)
- K(+)(in) = K(+)(out) (RHEA:29463)
UniProt features (34 total): topological domain 8, transmembrane region 6, region of interest 6, compositionally biased region 5, glycosylation site 3, domain 2, chain 1, intramembrane region 1, short sequence motif 1, sequence variant 1
Structure
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9UQ05-F1 | 67.69 | 0.26 |
Human Protein Atlas
Protein class: Voltage-gated ion channels, Voltage-Gated Potassium Channels, Predicted membrane proteins, UniProt - Evidence at transcript level
Protein evidence: Evidence at transcript level
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (3)
| Type | Positions |
|---|---|
| N-linked (glcnac…) asparagine | 326, 414, 473 |
Function
Pathways and Gene Ontology
Reactome pathways
1 curated (TAS) of 3; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
3 pathways:
| ID | Pathway | Evidence |
|---|---|---|
| R-HSA-1296072 | Voltage gated Potassium channels | curated |
| R-HSA-112316 | Neuronal System | — |
| R-HSA-1296071 | Potassium Channels | — |
MSigDB gene sets: 388 (showing top):
PID_BCR_5PATHWAY, GOBP_POTASSIUM_ION_TRANSPORT, RNGTGGGC_UNKNOWN, GOBP_RESPONSE_TO_ETHANOL, GOBP_HEPATICOBILIARY_SYSTEM_DEVELOPMENT, GOBP_RESPONSE_TO_IONIZING_RADIATION, BIOCARTA_FMLP_PATHWAY, REACTOME_INNATE_IMMUNE_SYSTEM, REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS, REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM, GOBP_CELLULAR_RESPONSE_TO_LIPID, REACTOME_POTASSIUM_CHANNELS, KEGG_MAPK_SIGNALING_PATHWAY, GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP, AAGCCAT_MIR135A_MIR135B
GO Biological Process (6): potassium ion transport (GO:0006813), regulation of membrane potential (GO:0042391), potassium ion transmembrane transport (GO:0071805), monoatomic ion transport (GO:0006811), monoatomic ion transmembrane transport (GO:0034220), transmembrane transport (GO:0055085)
GO Molecular Function (3): voltage-gated potassium channel activity (GO:0005249), monoatomic ion channel activity (GO:0005216), potassium channel activity (GO:0005267)
GO Cellular Component (4): plasma membrane (GO:0005886), voltage-gated potassium channel complex (GO:0008076), membrane (GO:0016020), monoatomic ion channel complex (GO:0034702)
Reactome top-level categories
2 top-level categories:
| Category | Pathways |
|---|---|
| Potassium Channels | 1 |
| Neuronal System | 1 |
GO top-level categories
21 GO namespaces:
| Category | Terms |
|---|---|
| transport | 2 |
| metal ion transport | 1 |
| monoatomic ion transmembrane transport | 1 |
| regulation of biological quality | 1 |
| potassium ion transport | 1 |
| monoatomic cation transmembrane transport | 1 |
| monoatomic ion transport | 1 |
| transmembrane transport | 1 |
| cellular process | 1 |
| potassium channel activity | 1 |
| voltage-gated monoatomic cation channel activity | 1 |
| monoatomic ion transmembrane transporter activity | 1 |
| channel activity | 1 |
| monoatomic cation channel activity | 1 |
| potassium ion transmembrane transporter activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| potassium channel complex | 1 |
| plasma membrane protein complex | 1 |
| cellular anatomical structure | 1 |
| transmembrane transporter complex | 1 |
Protein interactions and networks
STRING
showing 15 of 710 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KCNH4 | GHDC | Q8N2G8 | 713 |
| KCNH4 | DHX58 | Q96C10 | 679 |
| KCNH4 | KCNG1 | Q9UIX4 | 523 |
| KCNH4 | KCNF1 | Q9H3M0 | 516 |
| KCNH4 | HCRT | O43612 | 486 |
| KCNH4 | PRSS12 | P56730 | 479 |
| KCNH4 | KCNS2 | Q9ULS6 | 478 |
| KCNH4 | COL24A1 | Q17RW2 | 473 |
| KCNH4 | TBC1D31 | Q96DN5 | 455 |
| KCNH4 | KCNA10 | Q16322 | 436 |
| KCNH4 | STAT5B | P51692 | 421 |
| KCNH4 | C1QL2 | Q7Z5L3 | 404 |
| KCNH4 | KAT2A | Q92830 | 399 |
| KCNH4 | KCNV1 | Q6PIU1 | 392 |
| KCNH4 | SCN3B | Q9NY72 | 384 |
IntAct
Human interaction partners of KCNH4 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
1 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| ARFGEF2 | association | 0.350 | 1 |
BioGRID (11 interactions; top human partners by supporting records): ARFGEF1 (Affinity Capture-MS), ARFGEF2 (Affinity Capture-MS), DDX39A (Affinity Capture-RNA), DDX58 (Affinity Capture-RNA), KCNH1 (Negative Genetic), KCNH2 (Negative Genetic), KCNH3 (Negative Genetic), KCNH5 (Negative Genetic), KCNH6 (Negative Genetic), KCNH8 (Negative Genetic), TUBB7P (Affinity Capture-MS)
Protein complexes (CORUM) (1)
Experimentally-characterized complexes this protein is a subunit of (★ = the complex contains a known drug target).
1 complexes by size:
| Complex | Subunits | Members |
|---|---|---|
| ★ KCNH4-KCNH8 complex | 2 | KCNH4, KCNH8 |
Disease & clinical
Genetic variants
Variant evidence for KCNH4: 135 ClinVar records (0 pathogenic / likely pathogenic); 4 GWAS associations.
ClinVar
135 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 123 |
| Likely benign | 6 |
| Benign | 1 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 34 predictions of 1,717):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 17:42166295–42166296 | donor_loss | 1.0000 | 5 |
| 17:42169475–42169476 | donor_loss | 1.0000 | 4 |
| 17:42171997 | acceptor_loss | 1.0000 | 3 |
| 17:42175577–42175578 | donor_loss | 1.0000 | 5 |
| 17:42176052–42176053 | donor_loss | 1.0000 | 5 |
| 17:42178119 | donor_gain | 1.0000 | |
| 17:42178791–42178792 | donor_loss | 1.0000 | 3 |
| 17:42178795 | donor_gain | 1.0000 | |
| 17:42179027–42179028 | acceptor_loss | 1.0000 | 6 |
| 17:42166295 | donor_loss | 0.9900 |
AlphaMissense
2,122 missense substitutions predicted likely pathogenic (of 6,543 scored), across 498 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| M460 | 9 | 0.926 | 0.994 |
| M61 | 9 | 0.883 | 0.979 |
| D312 | 8 | 0.992 | 0.997 |
| F442 | 8 | 0.992 | 1.000 |
| F471 | 8 | 0.992 | 0.999 |
| F274 | 8 | 0.985 | 0.997 |
| D277 | 8 | 0.985 | 0.992 |
| N12 | 8 | 0.977 | 0.995 |
| F49 | 8 | 0.973 | 0.999 |
| F369 | 8 | 0.973 | 0.998 |
| H374 | 8 | 0.973 | 0.994 |
| F29 | 8 | 0.972 | 0.998 |
| D588 | 8 | 0.967 | 0.993 |
| N444 | 8 | 0.966 | 0.999 |
| D617 | 8 | 0.965 | 0.989 |
| F14 | 8 | 0.964 | 0.998 |
| F557 | 8 | 0.961 | 0.985 |
| F455 | 8 | 0.957 | 0.993 |
| D542 | 8 | 0.957 | 0.989 |
| F69 | 8 | 0.956 | 0.996 |
HPA cancer prognostics
RNA cancer specificity: Not detected
Disease associations
OMIM: gene MIM:604528 | disease phenotypes:
GWAS associations
4 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST004278_26 | Pulse pressure | 3e-9 |
| GCST004278_7 | Pulse pressure | 3e-9 |
| GCST004278_35 | Pulse pressure | 6e-8 |
| GCST004278_48 | Pulse pressure | 4e-7 |
EFO canonical traits (from GWAS)
1 canonical traits:
| EFO ID | Trait name |
|---|---|
| EFO:0005763 | pulse pressure measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL2362996 (PROTEIN FAMILY)
PharmGKB: 1 entry (CPIC guideline: no)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: vgic — Voltage-gated potassium channels (Kv)
ChEMBL bioactivities
2 potent at pChembl≥5 of 2 total, top 2 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 9.82 | Ki | 0.15 | nM | CHEMBL5722941 |
| 9.74 | IC50 | 0.18 | nM | CHEMBL5722941 |
PubChem BioAssay actives
2 with measured affinity, of 34 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 3-[(1R,2aS,4S,5aS,8aS,10S,11aR,14aS,16S,17aS,19S,20aS,22S,23aS,25S,26aS,28S,29aS,31R,32aS,35aS,36R,38aS,39S,41aS,42S,44aS,45S,48R,50aS,51S,53aS,54S,56aS,57S,59aS,60S,63S,66S,69S,72S,75S,78S,87R,93S,96S,99S)-17a,20a,23a,53a,63-pentakis(4-aminobutyl)-31-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-5-carbamimidamido-2-[[(2S)-5-carbamimidamido-2-[[(2S)-1-[(2S)-5-oxopyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]pentanoyl]amino]pentanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-16,29a,72,78-tetrakis(2-amino-2-oxoethyl)-14a,26a-bis(3-amino-3-oxopropyl)-2a,38a,66-tribenzyl-28,50a,57-tris[(2S)-butan-2-yl]-4,5a,19,42,45,69-hexakis(3-carbamimidamidopropyl)-51,54-bis(2-carboxyethyl)-56a,99-bis(carboxymethyl)-36-[[(2S,3S)-1-(carboxymethylamino)-3-methyl-1-oxopentan-2-yl]carbamoyl]-39,60-bis[(1R)-1-hydroxyethyl]-75,93-bis(hydroxymethyl)-32a,35a,59a-tris[(4-hydroxyphenyl)methyl]-22-(1H-imidazol-4-ylmethyl)-96-(1H-indol-3-ylmethyl)-41a-methyl-25-(2-methylpropyl)-1a,3,4a,6,7a,9,10a,13a,15,16a,18,19a,21,22a,24,25a,27,28a,30,31a,34a,37a,38,40a,41,43a,44,47,49a,50,52a,53,55a,56,58a,59,61a,62,65,68,71,74,77,80,83,86,89,92,95,98-pentacontaoxo-33,34,63a,64a,67a,68a-hexathia-a,2,3a,5,6a,8,9a,12a,14,15a,17,18a,20,21a,23,24a,26,27a,29,30a,33a,36a,37,39a,40,42a,43,46,48a,49,51a,52,54a,55,57a,58,60a,61,64,67,70,73,76,79,82,85,88,91,94,97-pentacontazapentacyclo[85.74.4.448,111.010,14.0144,148]nonahexacontahectan-8a-yl]propanoic acid | 2198828: Binding affinity to KV channel (unknown origin) assessed as inhibition constant | ki | 0.0001 | uM |
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases expression | 2 |
| benzo(e)pyrene | increases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Ivermectin | increases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Tretinoin | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Sodium Selenite | decreases expression | 1 |
| Coal Ash | increases expression | 1 |
ChEMBL screening assays
21 unique, capped per target: 20 binding, 1 toxicity
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL1787442 | Binding | Inhibition of human recombinant Kv channel at 10 uM by radioligand binding assay | Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement. — *Bioorg Med Chem Lett* |
| CHEMBL5522525 | Toxicity | Inhibition of human K+ channel by automated electrophysiology | Discovery of Clinical Candidate AZD5462, a Selective Oral Allosteric RXFP1 Agonist for Treatment of Heart Failure. — *J Med Chem* |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.